Research Article

Counting Footsteps with a Pedometer to Improve HMW Adiponectin and Metabolic Syndrome among Young Female Adults in the United Arab Emirates

Table 1

Changes in the anthropometric measurements, blood pressure, and biochemical measurements of participants before and after intervention ().

VariablesBefore intervention (baseline)After intervention (after 9 weeks) value

Weight (kg)70.6 ± 15.669.9 ± 15.20.002
Body mass index (kg/m2)27.5 ± 5.627.2 ± 5.490.002
Body fat mass (kg)29.13 ± 11.928.08 ± 11.820.001
Visceral fat area (cm2)98.15 ± 32.394.94 ± 29.30.007
Fat-free mass (kg)41.7 ± 4.742.2 ± 5.40.117
Percentage of body fat (%)39.8 ± 7.7938.7 ± 8.230.011
Waist-hip ratio0.907 ± 0.060.901 ± 0.060.025
Waist circumference (cm)80.9 ± 13.6879.55 ± 12.430.007
Systolic blood pressure (mmHg)113.79 ± 7.24114.4 ± 4.710.57
Diastolic blood pressure (mmHg)75.38 ± 5.7674.9 ± 2.110.60
Total cholesterol (mg/dl)122.17 ± 23.21118.69 ± 28.540.30
Triglycerides (mg/dl)64.29 ± 25.060.48 ± 26.400.09
High-density lipoprotein cholesterol (mg/dl)45.5 ± 8.2247.43 ± 12.070.25
Low-density lipoprotein cholesterol (mg/dl)63.80 ± 18.0459.17 ± 18.610.01
High-molecular-weight adiponectin (µg/ml)4.08 ± 0.554.15 ± 0.530.03
Glucose (mg/dl)72.62 ± 8.8172.88 ± 10.840.85
Insulin (µU/l)20.09 ± 8.5018.40 ± 8.470.24
HOMA-IR3.64 ± 1.703.47 ± 2.050.55